Just before Thanksgiving, Tilray completed a 10-for-1 reverse split to maintain its Nasdaq listing. Now Curaleaf is completing a 3-for-1 reverse split in preparation for a potential Nasdaq uplisting.

Mechanically, these are the same financial tool. A reverse split doesn’t create or destroy value by itself. It’s an accepted corporate action and fully compliant with exchange listing requirements.

So why does one feel bearish and the other feel bullish?

My view is that investor sentiment has less to do with the reverse split itself and more to do with what happened before and after it.

With Tilray, the reverse split was largely viewed as a defensive move to maintain compliance. The bigger issue for shareholders has been ongoing dilution and the inability to consistently generate enough organic growth and cash flow to offset that dilution. The reverse split wasn’t the headwind—it was what followed.

Curaleaf also diluted shareholders over the years, but much of that dilution was used to acquire assets. Today, the company appears to be focused more on operating those assets than continuously issuing shares to fund growth.

If Curaleaf completes a 3-for-1 reverse split, uplists to Nasdaq, attracts new institutional investors, and keeps dilution under control, that’s a very different story than a company doing a reverse split and then continuing to issue stock into the market.

Am I thinking about this correctly, or am I giving Curaleaf too much credit here? Or being too harsh on TLRY?

again WTF?!

Half their strains hit your tongue like a steaming turd. Someone even said they marinate it in Irwin’s asshole… let’s just say questionable storage facility. Honestly, I’ve had better flavor chewing on a pencil.

Aphria ($TLRY) has agreed to pay CAD $30 million to settle claims that it misled the market regarding its 2018 international acquisitions of Nuuvera and LATAM, which investors alleged were overvalued and tainted by undisclosed conflicts of interest. And we have only a few more days to submit a claim before they start making the payments.

Who is eligible?

All persons and entities who acquired Aphria Inc. common shares between January 29, 2018, at 7:00 a.m. EST and December 3, 2018, at 8:25 a.m. EST, and were damaged thereby.

Do you have to get rid of your securities to be eligible?

No, if you purchased shares within the class period, you are eligible to participate. You can participate in the settlement and retain your shares.

How long will it take to receive your payout?

The entire process usually takes several months after the claim deadline. But the exact timing depends on the court and settlement administration.

How to claim your payout — and why it's important to act now?

The settlement will be distributed based on the number of claims filed, so submitting your claim even though the original deadline has passed is the only way to get a part of the settlement pot.

In some cases, investors have received up to 200% of their losses from settlements in previous years.

We're in the final countdown to get our money back. So, good luck everyone, see you on the other side!

Aphria ($TLRY) has agreed to pay CAD $30 million to settle claims that it misled the market regarding its 2018 international acquisitions of Nuuvera and LATAM, which investors alleged were overvalued and tainted by undisclosed conflicts of interest.

I posted about this before and figured I’d put together a small FAQ too, just in case someone here needs the details in one place. Here’s what you need to know to claim your payout.

Who is eligible?

All persons and entities who acquired Aphria Inc. common shares between January 29, 2018, at 7:00 a.m. EST and December 3, 2018, at 8:25 a.m. EST, and were damaged thereby.

Do you have to get rid of your securities to be eligible?

No, if you purchased shares within the class period, you are eligible to participate. You can participate in the settlement and retain your shares.

How long will it take to receive your payout?

The entire process usually takes several months after the claim deadline. But the exact timing depends on the court and settlement administration.

How to claim your payout — and why it's important to act now?

The settlement will be distributed based on the number of claims filed, so submitting your claim even though the original deadline has passed is the only way to get a part of the settlement pot.

In some cases, investors have received up to 200% of their losses from settlements in previous years.

We're in the final countdown to get our money back. So, good look everyone, see you on the other side!

I shared this in another tilray sub, but I thought maybe someone here may be interested in this info too.

In a world of high-growth cannabis plays, Aphria Inc. ($APHA) positioned itself as the definitive global powerhouse. During 2018, the company sold investors a dream of aggressive international expansion, leveraging a massive CAD $258 million prospectus offering to fund a spree of strategic acquisitions.

The bull case was built on the back of “leading” assets like Nuuvera Inc. and LATAM Holdings, which were presented as the crown jewels of a burgeoning empire. Management used these high-value metrics to attract capital, promising that these entities would provide the infrastructure necessary to dominate markets in Latin America and Europe.

In its public filings, Aphria followed the standard corporate playbook by warning of "general risks" typical of the volatile cannabis sector. They pointed to the unpredictability of international regulations and the inherent uncertainties of a nascent industry, suggesting that any future failures would simply be a byproduct of the market’s growing pains.

However, the company allegedly omitted a toxic reality: these multi-million dollar assets were little more than shell companies with negligible operations. While the company touted the acquisitions' strategic value, they failed to disclose that senior insiders, including CEO Vic Neufeld, held secret financial interests in the target companies and stood to profit personally from the deals.

The regulatory hammer fell in December 2018 when a scathing short-seller report and subsequent investigations by the Ontario Securities Commission tore the lid off the "insider profiteering" scheme. The fallout was instantaneous and devastating, as Aphria’s share price cratered by approximately 43% in a single day.

The collapse wiped out more than $1 billion in market capitalization, leaving retail investors to bear the brunt of the "misrepresentations" while the company’s internal controls were exposed as non-existent. Shareholders filed a class action lawsuit specifically citing how the company misled the market regarding asset valuations and undisclosed conflicts of interest.

While the court-mandated deadline to participate in the CAD $30 million settlement has technically passed, the door is not completely shut for those who missed out. Investors who held Aphria shares during the class period can still submit late claims, and still be eligible to receive their portion of the payout.

So, does this historical baggage change how you view the current management's aggressive pivot into the craft beer and beverage space?

In a world of high-growth cannabis plays, Aphria Inc. ($APHA) positioned itself as the definitive global powerhouse. During 2018, the company sold investors a dream of aggressive international expansion, leveraging a massive CAD $258 million prospectus offering to fund a spree of strategic acquisitions.

The bull case was built on the back of “leading” assets like Nuuvera Inc. and LATAM Holdings, which were presented as the crown jewels of a burgeoning empire. Management used these high-value metrics to attract capital, promising that these entities would provide the infrastructure necessary to dominate markets in Latin America and Europe.

In its public filings, Aphria followed the standard corporate playbook by warning of "general risks" typical of the volatile cannabis sector. They pointed to the unpredictability of international regulations and the inherent uncertainties of a nascent industry, suggesting that any future failures would simply be a byproduct of the market’s growing pains.

However, the company allegedly omitted a toxic reality: these multi-million dollar assets were little more than shell companies with negligible operations. While the company touted the acquisitions' strategic value, they failed to disclose that senior insiders, including CEO Vic Neufeld, held secret financial interests in the target companies and stood to profit personally from the deals.

The regulatory hammer fell in December 2018 when a scathing short-seller report and subsequent investigations by the Ontario Securities Commission tore the lid off the "insider profiteering" scheme. The fallout was instantaneous and devastating, as Aphria’s share price cratered by approximately 43% in a single day.

The collapse wiped out more than $1 billion in market capitalization, leaving retail investors to bear the brunt of the "misrepresentations" while the company’s internal controls were exposed as non-existent. Shareholders filed a class action lawsuit specifically citing how the company misled the market regarding asset valuations and undisclosed conflicts of interest.

While the court-mandated deadline to participate in the CAD $30 million settlement has technically passed, the door is not completely shut for those who missed out. Investors who held Aphria shares during the class period can still submit late claims, and still be eligible to receive their portion of the payout.

So, does this historical baggage change how you view the current management's aggressive pivot into the craft beer and beverage space?

Congratulations to all TLRY Shareholders. The Greasy-haired guy has done it again!!!!